Altered mitogen-activated protein kinase signaling in dystrophic (mdx) muscle

Gayle M Smythe1, Jade K Forwood

  • 1School of Community Health, Charles Sturt University, P.O. Box 789, Albury, NSW, 2640, Australia. gsmythe@csu.edu.au

Muscle & Nerve
|August 22, 2012
PubMed
Abstract

Insights

Duchenne muscular dystrophy (DMD) involves altered mitogen-activated protein (MAP) kinase signaling, making muscle cells more vulnerable to stress. Targeting these MAP kinase pathways could offer new treatments for DMD.

Area of Science:

  • Molecular Biology
  • Cellular Biology
  • Biochemistry

Background:

  • Duchenne muscular dystrophy (DMD) is caused by dystrophin deficiency, leading to muscle cell susceptibility to stress.
  • Altered pro-survival signaling pathways are implicated in dystrophic myotubes, but the role of mitogen-activated protein (MAP) kinases remains unexplored.

Purpose of the Study:

  • To investigate the role of MAP kinase signaling pathways in the context of Duchenne muscular dystrophy.
  • To examine the phosphorylation patterns of key MAP kinase proteins in dystrophic muscle cells and tissue.

Main Methods:

  • Cultured myotubes from dystrophic (mdx) and wild-type mice were subjected to oxidative stress.
  • Phosphorylation patterns of key MAP kinase proteins were analyzed in vitro and in muscle tissue samples in vivo.

Main Results:

  • Dystrophic myotubes exhibited increased susceptibility to oxidant-induced cell death compared to wild-type.
  • This heightened susceptibility correlated with late c-Jun N-terminal kinase (JNK) phosphorylation and sustained p38 MAP kinase phosphorylation in mdx myotubes.
  • Altered phosphorylation levels of JNK and extracellular signal-regulated kinase 1/2 (ERK1/2) were observed in mdx muscle tissue.

Conclusions:

  • Significant alterations in MAP kinase protein phosphorylation were identified in dystrophic muscle, both in vitro and in vivo.
  • These findings suggest that MAP kinase signaling pathways represent potential novel pharmacological targets for therapeutic intervention in DMD.

Related Concept Videos

Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...